Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nutritional status at diagnosis in children with cancer I. An assessment by dietary recall--compared with body mass index and body composition measured by dual energy X-ray absorptiometry.
Collins L, Nayiager T, Doring N, Kennedy C, Webber C, Halton J, Walker S, Sala A, Barr RD. Collins L, et al. Among authors: walker s. J Pediatr Hematol Oncol. 2010 Nov;32(8):e299-303. doi: 10.1097/MPH.0b013e3181e9e43c. J Pediatr Hematol Oncol. 2010. PMID: 20962676 Clinical Trial.
Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy.
Phung K, McAdam L, Ma J, McMillan HJ, Jackowski S, Scharke M, Matzinger MA, Shenouda N, Koujok K, Jaremko JL, Smit K, Walker S, Hartigan C, Khan N, Konji VN, MacLeay L, Page M, Sykes E, Robinson ME, Alos N, Cummings EA, Ho J, Sbrocchi AM, Stein R, Saleh D, Craven BC, Dang UJ, Siminoski K, Rauch F, Ward LM. Phung K, et al. Among authors: walker s. Osteoporos Int. 2023 Jan;34(1):147-160. doi: 10.1007/s00198-022-06578-6. Epub 2022 Nov 7. Osteoporos Int. 2023. PMID: 36342539
Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy.
Phung K, McAdam L, Ma J, McMillan HJ, Jackowski S, Scharke M, Matzinger MA, Shenouda N, Koujok K, Jaremko JL, Wilson N, Walker S, Hartigan C, Khan N, Page M, Robinson ME, Saleh DS, Smit K, Rauch F, Siminoski K, Ward LM. Phung K, et al. Among authors: walker s. J Clin Endocrinol Metab. 2024 Jan 18;109(2):536-548. doi: 10.1210/clinem/dgad435. J Clin Endocrinol Metab. 2024. PMID: 37610420
Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI.
Seale E, Molina MO, Carsen S, Sheffield H, Koujok K, Robinson ME, Feber J, Smit K, Page M, Walker S, Khan N, Konji VN, Rauch F, Ward LM. Seale E, et al. Among authors: walker s. Calcif Tissue Int. 2023 May;112(5):613-620. doi: 10.1007/s00223-023-01065-4. Epub 2023 Mar 3. Calcif Tissue Int. 2023. PMID: 36867194
Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement.
Kanji S, Hayes M, Ling A, Shamseer L, Chant C, Edwards DJ, Edwards S, Ensom MH, Foster DR, Hardy B, Kiser TH, la Porte C, Roberts JA, Shulman R, Walker S, Zelenitsky S, Moher D. Kanji S, et al. Among authors: walker s. Clin Pharmacokinet. 2015 Jul;54(7):783-95. doi: 10.1007/s40262-015-0236-8. Clin Pharmacokinet. 2015. PMID: 25637173
5,528 results